Business Description
Rakovina Therapeutics Inc
NAICS : 541714
SIC : 3741
ISIN : CA75103L1013
Description
Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some f its products in the pipeline include kt-2000 AI, kt-3000 series.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | -0.69 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.57 | |||||
| 9-Day RSI | 52.87 | |||||
| 14-Day RSI | 52.67 | |||||
| 6-1 Month Momentum % | 20 | |||||
| 12-1 Month Momentum % | -30.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.08 | |||||
| Quick Ratio | 4.08 | |||||
| Cash Ratio | 2.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -53.63 | |||||
| ROA % | -44.95 | |||||
| ROIC % | -50.73 | |||||
| ROC (Joel Greenblatt) % | -1846.44 | |||||
| ROCE % | -43.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.73 | |||||
| EV-to-EBIT | -2.92 | |||||
| EV-to-EBITDA | -3.73 | |||||
| EV-to-FCF | -3.87 | |||||
| Earnings Yield (Greenblatt) % | -34.25 | |||||
| FCF Yield % | -29.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rakovina Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.04 | ||
| Beta | 0.21 | ||
| Volatility % | 80.51 | ||
| 14-Day RSI | 52.67 | ||
| 14-Day ATR (C$) | 0.004063 | ||
| 20-Day SMA (C$) | 0.0885 | ||
| 12-1 Month Momentum % | -30.77 | ||
| 52-Week Range (C$) | 0.005 - 0.14 | ||
| Shares Outstanding (Mil) | 70.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rakovina Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rakovina Therapeutics Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rakovina Therapeutics Inc Frequently Asked Questions
What is Rakovina Therapeutics Inc(TSXV:RKV)'s stock price today?
The current price of TSXV:RKV is C$0.09. The 52 week high of TSXV:RKV is C$0.14 and 52 week low is C$0.01.
When is next earnings date of Rakovina Therapeutics Inc(TSXV:RKV)?
The next earnings date of Rakovina Therapeutics Inc(TSXV:RKV) is .
Does Rakovina Therapeutics Inc(TSXV:RKV) pay dividends? If so, how much?
Rakovina Therapeutics Inc(TSXV:RKV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers